ÂÜÀòÂÒÂ×

Nuvalent

1 follower

‌

Nuvalent is creating precisely targeted therapies for patients with cancer designed to overcome the limitations of existing therapies for clinically proven kinase targets. Leveraging deep expertise in structure-based design, Nuvalent develops innovative small molecules with exquisite target selectiv... Read more

Employees

11-50

Links

Org chart

James Porter

Collapse
Deb Miller
Chief Legal Officer
Darlene Noci
Chief Development Officer
Henry Pelish
SVP, Drug Discovery
Jessie Lin
VP, Corporate Strategy & Portfolio Management
Matthew Metivier
VP, Human Resources
Philip Engel
Director, Cybersecurity & Compliance